MetLife, Inc. (NYSE:MET) Position Cut by Choreo LLC

Choreo LLC lowered its holdings in shares of MetLife, Inc. (NYSE:MET) by 5.2% during the 4th quarter, Holdings Channel reports. The fund owned 63,095 shares of the financial services provider’s stock after selling 3,449 shares during the period. Choreo LLC’s holdings in MetLife were worth $5,150,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in the business. Tectonic Advisors LLC increased its stake in shares of MetLife by 2.7% during the fourth quarter. Tectonic Advisors LLC now owns 14,370 shares of the financial services provider’s stock valued at $1,177,000 after acquiring an additional 377 shares during the period. Confluence Wealth Services Inc. boosted its stake in MetLife by 51.3% during the 4th quarter. Confluence Wealth Services Inc. now owns 9,147 shares of the financial services provider’s stock valued at $794,000 after purchasing an additional 3,103 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of MetLife by 36.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 50,371 shares of the financial services provider’s stock valued at $4,118,000 after purchasing an additional 13,554 shares during the period. Y.D. More Investments Ltd lifted its holdings in shares of MetLife by 109.9% in the fourth quarter. Y.D. More Investments Ltd now owns 718 shares of the financial services provider’s stock valued at $59,000 after buying an additional 376 shares during the period. Finally, Hager Investment Management Services LLC bought a new position in MetLife during the fourth quarter valued at about $252,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Up 0.3 %

Shares of MetLife stock opened at $84.92 on Thursday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 1 year low of $65.65 and a 1 year high of $89.05. The stock has a 50-day moving average price of $83.96 and a 200 day moving average price of $80.68. The company has a market cap of $58.80 billion, a P/E ratio of 17.12, a P/E/G ratio of 0.66 and a beta of 1.07.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 5.27% and a return on equity of 20.01%. As a group, analysts expect that MetLife, Inc. will post 8.18 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.57%. MetLife’s dividend payout ratio is 43.95%.

Analyst Ratings Changes

Several equities research analysts have commented on MET shares. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. TD Cowen increased their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Wells Fargo & Company decreased their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 14th. BMO Capital Markets began coverage on MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective for the company. Finally, StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and a consensus price target of $91.17.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.